Special Considerations and Clinical Management of HIV in Patients With Substance Use Disorder
Summary
- Standard dosing of tipranavir/ritonavir 500/200 mg twice daily may result in a decrease in methadone levels requiring an increase in methadone dose[FDA Tipranavir]
- Buprenorphine levels are not significantly decreased with tipranavir/ritonavir 500/200 mg twice daily[Bruce 2009a]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content